|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/64 | (2006.01) |
| C12N 9/6432 | (2013.01) | ||
| C07K 1/22 | (2006.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Patento numeris | 3926044 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21164923.1 |
| Europos patento paraiškos padavimo data | 2017-06-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-12-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2025-06-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201662351841 P | 2016-06-17 | US |
| (72) |
KARBARZ, Mark , US
CONLEY, Pamela B. , US
LU, Genmin , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | PREPARATION OF FACTOR XA DERIVATIVES |
| PREPARATION OF FACTOR XA DERIVATIVES |